This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (11)  • Contact me when this article is cited  Related Content  • Related letter  • Related articles  • Similar articles in JAMA  Topic Collections  • Thrombolysis  • Neurology  • Cerebrovascular Disease  • Patient-Physician Relationship/ Care  • Patient Education/ Health Literacy  • Cardiovascular System  • Cardiovascular Intervention  • Alert me on articles by topic  Social Bookmarking   What's this?

What's Missing From This Picture?

Phil B. Fontanarosa, MD; Margaret A. Winker, MD

JAMA. 1998;279:1307-1309.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Stroke is the third leading cause of death and the leading cause of serious, long-term disability in adults,¹ accounting for an estimated $30 billion to $40 billion in direct and indirect costs annually.² This staggering toll has prompted basic science and clinical researchers to transform the management of acute stroke from supportive therapy to an aggressive interventional strategy designed to actively restore cerebral perfusion and limit neurologic disability.^3-4 The success of this strategy, however, depends on several key components, few of which are currently in place.

In the ideal image of stroke as a treatable illness, every patient with acute ischemic stroke should present to a hospital stroke center immediately after the onset of symptoms, should be promptly and accurately diagnosed by a stroke team using sensitive neuroimaging studies, and should receive cerebral reperfusion and neuroprotective therapy based on his or her . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Reducing Treatment Delay and Improving Diagnostic Accuracy for Patients With Acute Stroke
Daniel Mines, Steven Rosenzweig, Justiniano F. Campa, Jonathan L. Stolz, Lombardo F. Palma, Antonio Villa, Marzia Bonacina, Sabina Paese, Ezio Omboni, David L. Schriger, Mary Kalafut, Sidney Starkman, Michelle Krueger, Jeffrey L. Saver, Arthur M. Pancioli, Joseph Broderick, Rashmi Kothari, Thomas Brott, Alfred Tuchfarber, Rosie Miller, Jane Khoury, Edward Jauch, Phil B. Fontanarosa, and Margaret A. Winker
JAMA. 1999;281(1):31-34.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Public Perception of Stroke Warning Signs and Knowledge of Potential Risk Factors
Arthur M. Pancioli, Joseph Broderick, Rashmi Kothari, Thomas Brott, Alfred Tuchfarber, Rosie Miller, Jane Khoury, and Edward Jauch
JAMA. 1998;279(16):1288-1292.
ABSTRACT | FULL TEXT  

Cranial Computed Tomography Interpretation in Acute Stroke: Physician Accuracy in Determining Eligibility for Thrombolytic Therapy
David L. Schriger, Mary Kalafut, Sidney Starkman, Michelle Krueger, and Jeffrey L. Saver
JAMA. 1998;279(16):1293-1297.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Reasons why few patients with acute stroke receive tissue plasminogen activator.
Bambauer et al.
Arch Neurol 2006;63:661-664.
ABSTRACT | FULL TEXT  

Qualitative Studies of Stroke: A Systematic Review
McKevitt et al.
Stroke 2004;35:1499-1505.
ABSTRACT | FULL TEXT  

Stroke in Devon: knowledge was good, but action was poor
Carroll et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:567-571.
ABSTRACT | FULL TEXT  

Reducing Treatment Delay and Improving Diagnostic Accuracy for Patients With Acute Stroke
Mines et al.
JAMA 1999;281:31-34.
FULL TEXT